Research article

Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy

Martin Luther Koanga Mogtomo¹ , Louise Carole Gouabe Malieugoue¹ , Carolle Djiepgang¹ , Michel Wankam² , Andre Moune³ and Annie Ngono Ngane¹

¹  Laboratory of Viral Oncology, Department of Biochemistry, Faculty of Sciences, University of Douala, Cameroon

²  Aids Care Unit and Gynaecology, Bonassama Hospital Douala, Cameroon

³  Pathology Unit, Douala General Hospital, Cameroon

author email corresponding author email

Infectious Agents and Cancer 2009, 4:9doi:10.1186/1750-9378-4-9

Published:	3 June 2009

Abstract

Background

Women infected with human immunodeficiency virus (HIV) may be at higher risk of developing cervical cancer than non infected women. In a pilot study, we assessed the relationships among cervical cytology abnormalities associated to Human Papillomavirus (HPV), HIV infection and Highly Active Antiretroviral Therapy (HAART) on the development of Squamous Intraepithelial lesions (SILs). Out of the 70 HIV infected women from Douala -Cameroon (Central Africa) that we included in the study, half (35) were under HAART. After obtaining information related to their lifestyle and sexual behaviour, cervicovaginal samples for Pap smears and venous blood for CD4 count were collected and further divided into two groups based upon the presence or absence of cervical cytology abnormalities i.e. those with normal cervical cytology and those with low and high Squamous Intraepithelial lesions (LSIL, HSIL).

Results

Assessment was done according to current antiretroviral regimens available nationwide and CD4 count. It was revealed that 44.3% of HIV-infected women had normal cytology. The overall prevalence of LSIL and HSIL associated to HPV in the studied groups was 24.3% (17/70) and 31.4% (22/70) respectively. Among the 22 HSIL-positive women, 63.6% (14/22) were not on antiretroviral therapy, while 36.4% (8/22) were under HAART. HIV infected women under HAART with positive HSIL, showed a median CD4+ T cell count of 253.7 +/- 31.7 higher than those without therapy (164.7 +/- 26.1). The incidence of HSIL related to HPV infection within the study group independently of HAART initiation was high.

Conclusion

These results suggest the need for extension and expansion of the current study in order to evaluate the incidence of HPV infection and cervical cancer among HIV-infected and non HIV- infected women in Cameroon.